Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-40,000
Closed -$393K 97
2025
Q2
$393K Sell
40,000
-804,441
-95% -$6.66M 0.02% 89
2025
Q1
$6.14M Buy
844,441
+291,700
+53% +$2.55M 0.35% 59
2024
Q4
$4.32M Buy
+552,741
New +$4.55M 0.16% 81

Other funds holding ETNB

Rock Springs Capital Management's ETNB Position: Q3 2025 in Review

Rock Springs Capital Management sold out of 89bio (ETNB) in Q3 2025, closing a stake of 40,000 shares — an estimated $393K sold.

Rock Springs Capital Management first reported a position in ETNB in Q4 2024 and held it in 3 quarters. The position peaked at $6.14M in Q1 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Rock Springs Capital Management reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Rock Springs Capital Management sold 40,000 89bio shares in Q3 2025, an estimated $393K.
  • Rock Springs Capital Management first reported a position in 89bio in Q4 2024 and held it in 3 quarters.
  • Rock Springs Capital Management's 89bio position peaked at $6.14M in Q1 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Rock Springs Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.